Assessment of lupus: where are we now?

Decisions about treatment for patients with SLE are based on numerous criteria, including the rate of change of clinical features and disease markers (especially antibodies to dsDNA and markers of complement turnover), which organ systems are affected, the severity of manifestations, and the presenc...

Celý popis

Podrobná bibliografie

Vydáno v:	Ann Rheum Dis
Hlavní autoři:	Hay, E, Gordon, C, Emery, P
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 1993
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005009/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8484667/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.3.169
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!